Innoviva Inc (INVA)
19.06
-0.09
(-0.47%)
USD |
NASDAQ |
Nov 21, 16:00
19.08
+0.02
(+0.08%)
After-Hours: 20:00
Innoviva Total Assets (Quarterly): 1.232B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 1.232B |
June 30, 2024 | 1.225B |
March 31, 2024 | 1.268B |
December 31, 2023 | 1.244B |
September 30, 2023 | 1.188B |
June 30, 2023 | 1.118B |
March 31, 2023 | 1.130B |
December 31, 2022 | 1.231B |
September 30, 2022 | 1.328B |
June 30, 2022 | 1.138B |
March 31, 2022 | 1.107B |
December 31, 2021 | 926.40M |
September 30, 2021 | 887.24M |
June 30, 2021 | 789.15M |
March 31, 2021 | 1.088B |
December 31, 2020 | 999.57M |
September 30, 2020 | 922.26M |
June 30, 2020 | 879.62M |
March 31, 2020 | 788.01M |
December 31, 2019 | 724.83M |
September 30, 2019 | 675.95M |
June 30, 2019 | 642.31M |
March 31, 2019 | 590.11M |
December 31, 2018 | 548.19M |
September 30, 2018 | 277.69M |
Date | Value |
---|---|
June 30, 2018 | 338.69M |
March 31, 2018 | 276.74M |
December 31, 2017 | 367.34M |
September 30, 2017 | 390.97M |
June 30, 2017 | 372.02M |
March 31, 2017 | 391.87M |
December 31, 2016 | 379.00M |
September 30, 2016 | 370.54M |
June 30, 2016 | 378.11M |
March 31, 2016 | 387.83M |
December 31, 2015 | 408.93M |
September 30, 2015 | 437.63M |
June 30, 2015 | 462.09M |
March 31, 2015 | 488.70M |
December 31, 2014 | 521.65M |
September 30, 2014 | 553.71M |
June 30, 2014 | 605.61M |
March 31, 2014 | 605.03M |
December 31, 2013 | 681.26M |
September 30, 2013 | 666.02M |
June 30, 2013 | 594.70M |
March 31, 2013 | 591.52M |
December 31, 2012 | 368.58M |
September 30, 2012 | 383.94M |
June 30, 2012 | 399.42M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
724.83M
Minimum
Dec 2019
1.328B
Maximum
Sep 2022
1.061B
Average
1.113B
Median
Total Assets (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 3.877M |
Palatin Technologies Inc | 3.415M |
iBio Inc | 24.52M |
Theriva Biologics Inc | 40.11M |
Oragenics Inc | 5.204M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 563.07M |
Shareholders Equity (Quarterly) | 668.54M |
Debt to Equity Ratio | 0.6698 |
Current Ratio | 1.790 |
Net Debt Paydown Yield | -0.04% |